BR112014030651A2 - inibidor de jak1 e jak2 - Google Patents
inibidor de jak1 e jak2Info
- Publication number
- BR112014030651A2 BR112014030651A2 BR112014030651A BR112014030651A BR112014030651A2 BR 112014030651 A2 BR112014030651 A2 BR 112014030651A2 BR 112014030651 A BR112014030651 A BR 112014030651A BR 112014030651 A BR112014030651 A BR 112014030651A BR 112014030651 A2 BR112014030651 A2 BR 112014030651A2
- Authority
- BR
- Brazil
- Prior art keywords
- jak1
- jak2 inhibitor
- jak2
- inhibitor
- methylmethyl
- Prior art date
Links
- 101150079478 jak1 gene Proteins 0.000 title abstract 3
- 229940116839 Janus kinase 1 inhibitor Drugs 0.000 title abstract 2
- 229940121730 Janus kinase 2 inhibitor Drugs 0.000 title abstract 2
- -1 amino pyrazole compound Chemical class 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261659679P | 2012-06-14 | 2012-06-14 | |
| PCT/US2013/044211 WO2013188184A1 (en) | 2012-06-14 | 2013-06-05 | Inhibitor of jak1 and jak2 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112014030651A2 true BR112014030651A2 (pt) | 2017-06-27 |
Family
ID=48626679
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112014030651A BR112014030651A2 (pt) | 2012-06-14 | 2013-06-05 | inibidor de jak1 e jak2 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9062050B2 (https=) |
| EP (1) | EP2861231B1 (https=) |
| JP (1) | JP6092376B2 (https=) |
| KR (1) | KR20150008907A (https=) |
| CN (1) | CN104349775B (https=) |
| AU (1) | AU2013274641B2 (https=) |
| BR (1) | BR112014030651A2 (https=) |
| CA (1) | CA2871659C (https=) |
| EA (1) | EA201492104A1 (https=) |
| ES (1) | ES2605827T3 (https=) |
| IN (1) | IN2014MN02228A (https=) |
| MX (1) | MX2014015271A (https=) |
| WO (1) | WO2013188184A1 (https=) |
| ZA (1) | ZA201407940B (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR105400A1 (es) * | 2015-08-04 | 2017-09-27 | Lilly Co Eli | Inhibidores de jak1 |
| US20220143049A1 (en) | 2019-03-21 | 2022-05-12 | Onxeo | A dbait molecule in combination with kinase inhibitor for the treatment of cancer |
| CN110229067A (zh) * | 2019-06-05 | 2019-09-13 | 南京焕然生物科技有限公司 | 一种2-氨基茚制备方法 |
| EP4054579A1 (en) | 2019-11-08 | 2022-09-14 | Institut National de la Santé et de la Recherche Médicale (INSERM) | Methods for the treatment of cancers that have acquired resistance to kinase inhibitors |
| WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
| CN115141195B (zh) * | 2021-03-03 | 2024-02-06 | 成都先导药物开发股份有限公司 | 一种nuak抑制剂及其用途 |
| TW202325289A (zh) | 2021-11-09 | 2023-07-01 | 美商雅捷可斯治療公司 | Ｊａｋ２抑制劑之形式及組合物 |
| CN116585312A (zh) * | 2023-04-30 | 2023-08-15 | 兰州大学第二医院 | 含苯氧基丙酸化合物的胰腺癌jak2和stat3双靶向抑制剂及应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1853588E (pt) | 2005-02-16 | 2008-08-25 | Astrazeneca Ab | Compostos químicos |
| TWI398252B (zh) * | 2006-05-26 | 2013-06-11 | 諾華公司 | 吡咯并嘧啶化合物及其用途 |
| WO2008129255A1 (en) * | 2007-04-18 | 2008-10-30 | Astrazeneca Ab | 5-aminopyrazol-3-yl-3h-imidazo [4,5-b] pyridine derivatives and their use for the treatment of cancer |
-
2013
- 2013-06-05 CA CA2871659A patent/CA2871659C/en not_active Expired - Fee Related
- 2013-06-05 IN IN2228MUN2014 patent/IN2014MN02228A/en unknown
- 2013-06-05 CN CN201380031385.1A patent/CN104349775B/zh not_active Expired - Fee Related
- 2013-06-05 JP JP2015517311A patent/JP6092376B2/ja not_active Expired - Fee Related
- 2013-06-05 EP EP13729215.7A patent/EP2861231B1/en not_active Not-in-force
- 2013-06-05 KR KR20147034683A patent/KR20150008907A/ko not_active Abandoned
- 2013-06-05 AU AU2013274641A patent/AU2013274641B2/en not_active Ceased
- 2013-06-05 ES ES13729215.7T patent/ES2605827T3/es active Active
- 2013-06-05 EA EA201492104A patent/EA201492104A1/ru unknown
- 2013-06-05 US US14/402,146 patent/US9062050B2/en not_active Expired - Fee Related
- 2013-06-05 BR BR112014030651A patent/BR112014030651A2/pt not_active IP Right Cessation
- 2013-06-05 MX MX2014015271A patent/MX2014015271A/es unknown
- 2013-06-05 WO PCT/US2013/044211 patent/WO2013188184A1/en not_active Ceased
-
2014
- 2014-10-30 ZA ZA2014/07940A patent/ZA201407940B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20150008907A (ko) | 2015-01-23 |
| CN104349775A (zh) | 2015-02-11 |
| IN2014MN02228A (https=) | 2015-07-17 |
| ZA201407940B (en) | 2016-05-25 |
| EP2861231A1 (en) | 2015-04-22 |
| EP2861231B1 (en) | 2016-08-31 |
| CA2871659A1 (en) | 2013-12-19 |
| JP2015519396A (ja) | 2015-07-09 |
| EA201492104A1 (ru) | 2015-06-30 |
| JP6092376B2 (ja) | 2017-03-08 |
| MX2014015271A (es) | 2015-03-05 |
| US20150133490A1 (en) | 2015-05-14 |
| CN104349775B (zh) | 2017-06-06 |
| ES2605827T3 (es) | 2017-03-16 |
| CA2871659C (en) | 2017-04-04 |
| AU2013274641B2 (en) | 2015-09-24 |
| AU2013274641A1 (en) | 2014-11-20 |
| WO2013188184A1 (en) | 2013-12-19 |
| US9062050B2 (en) | 2015-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112014030651A2 (pt) | inibidor de jak1 e jak2 | |
| PH12019501321B1 (en) | Use of pyrazolopyrimidine derivatives for the treatment of pi3k-delta related disorders | |
| PH12018500041A1 (en) | Substituted aza compoounds as irak-4 inhibitors | |
| CR20130550A (es) | Ciclopropilaminas como inhibidores de desmetilasa 1 específica de lisina | |
| PH12015500064A1 (en) | Imidazotriazinecarbonitriles useful as kinase inhibitors | |
| GT201300123A (es) | Sal(es) de dimetil-amida del acido 7-ciclopentil-2-(5-piperazin-1-il-piridin-2-il-amino)-7h-pirrolo-(2,3-d)-pirimidin-6-carboxilico y procesos para su elaboracion | |
| WO2014028589A3 (en) | 4-HETEROARYL SUBSTITUTED BENZOIC ACID COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF | |
| AU2012250958A8 (en) | Amino-pyridine-containing Spleen Tyrosine Kinase (Syk) inhibitors | |
| EA201491456A1 (ru) | Соединения-ингибиторы raf | |
| BR112012026767A2 (pt) | composto, sal farmaceuticamente aceitável de um composto, composição farmacêutica, método para tratar ou previnir distúrbios, e, uso de um composto ou sal | |
| BR112012028136A2 (pt) | terapia de combinaçao | |
| CU20160188A7 (es) | Compuestos de indazole substituidos como inhibidores de irak4 | |
| EA201491399A1 (ru) | Селективные ингибиторы cdk8/cdk19 и их применение в качестве противометастатических и химиопрофилактических агентов для лечения рака | |
| TN2013000237A1 (en) | Imidazo [4, 5 -c] quinolin- 2 -one compound and its use as pi3 kinase / mtor dual inhibitor | |
| BR112014002202A2 (pt) | macrociclos como inibidores de fator xia | |
| BR112016015236A2 (pt) | inibidores de serina/treonina quinase | |
| JO3115B1 (ar) | مركبات بيريدازينون واستخدامها كمثبطات daao | |
| MX362855B (es) | Derivados de quinazolinona como inhidores poli (adp-ribosa) polimerasa (parp). | |
| TN2015000261A1 (fr) | Dérivés d'imidazopyridazine servant de modulateurs des recepteurs gabaa | |
| EA201591175A1 (ru) | Трициклические соединения в качестве ингибиторов cftr | |
| BR112013033836A2 (pt) | terapia de combinação | |
| AU2012307449A8 (en) | Sulfonic acid salts of heterocyclylamide-substituted imidazoles | |
| AR089064A1 (es) | Inhibidores de la peptido desformilasa | |
| AR081783A1 (es) | Esteres de metronidazol para tratar rosacea | |
| TH149217A (th) | สารประกอบอิมิดาโซล[4,5-c]ควินอลิน-2-โอน และการใช้ของมันในรูปตัวยับยั้งคู่สำหรับ Pl3 คิเนส/MTOR |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law | ||
| B08F | Application fees: dismissal - article 86 of industrial property law | ||
| B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2465 DE 03-04-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |